Home › Plaveiselcelcarcinoom van hoofd en hals › Florida › Orlando
Plaveiselcelcarcinoom van hoofd en hals klinische studies in Orlando, FL
16 studies voor Plaveiselcelcarcinoom van hoofd en hals zoeken deelnemers op locaties in en rond Orlando (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruterenFase 1
- Exelixis Clinical Site #48, Celebration · 17 mijl verwijderd
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RekruterenFase 3
- AdventHealth Medical Group Oncology and Hematology at Orlando, Orlando
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
RekruterenFase 3
- AdventHealth Orlando, Orlando
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruterenFase 1
- Sara Cannon Research Institute Lake Nona, Orlando
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruterenFase 1/2
- Florida Cancer Specialists - Lake Nona, Orlando
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
RekruterenFase 2
- Orlando Health, Orlando
SMP-3124LP in Adults With Advanced Solid Tumors
RekruterenFase 1/2
- Advent Health, Celebration · 17 mijl verwijderd
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekruterenFase 1/2
- Clermont Oncology Center, Clermont · 24 mijl verwijderd
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- Sarah Cannon Research Institute (Lake Nona), Orlando
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RekruterenFase 1
- Florida Cancer Specialists - Lake Nona, Orlando
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruterenFase 1
- Florida Cancer Specialists, Orlando
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RekruterenFase 3
- AdventHealth Medical Group Oncology & Hematology at Orlando, Orlando
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Florida Cancer Specialists-Lake Nona, Orlando
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruterenFase 1
- Dren Investigational Site, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · 17 mijl verwijderd
Plaveiselcelcarcinoom van hoofd en hals studies in andere steden
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- New York City, NY39 studies
- Nashville, TN39 studies
- St. Louis, MO28 studies
- Arlington, VA26 studies
- Philadelphia, PA26 studies
- Chicago, IL26 studies
- Atlanta, GA24 studies
- San Antonio, TX22 studies
- New Haven, CT22 studies
Andere studies in Orlando
- Niet-kleincellige longkanker44 studies
- Obesitas32 studies
- Metastatische kanker29 studies
- Overgewicht27 studies
- Ziekte van Alzheimer25 studies
- Type 2-diabetes25 studies
- Kanker (alle vormen)24 studies
- Borstkanker23 studies
- Eierstokkanker22 studies
- Colitis ulcerosa22 studies
- Longkanker21 studies
- Colorectale kanker19 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.